Terms: = Head and neck cancer AND LMO2, RBTN2, 4005, ENSG00000135363, P25791, TTG2, RBTNL1, RHOM2 AND Treatment
1 results:
1. Genomic profiling and associated B cell lineages delineate the efficacy of neoadjuvant anti-PD-1-based therapy in oesophageal squamous cell carcinoma.
Zhang H; Wen H; Zhu Q; Zhang Y; Xu F; Ma T; Guo Y; Lu C; Zhao X; Ji Y; Wang Z; Chu Y; Ge D; Gu J; Liu R
EBioMedicine; 2024 Feb; 100():104971. PubMed ID: 38244291
[TBL] [Abstract] [Full Text] [Related]
